Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Inflammatory Th17 Cells Express Integrin αvβ3 for Pathogenic Function.

Du F, Garg AV, Kosar K, Majumder S, Kugler DG, Mir GH, Maggio M, Henkel M, Lacy-Hulbert A, McGeachy MJ.

Cell Rep. 2016 Aug 2;16(5):1339-1351. doi: 10.1016/j.celrep.2016.06.065. Epub 2016 Jul 21.

2.

IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.

Arbelaez CA, Glatigny S, Duhen R, Eberl G, Oukka M, Bettelli E.

J Immunol. 2015 Sep 1;195(5):1974-83. doi: 10.4049/jimmunol.1403135. Epub 2015 Jul 29.

3.

Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.

Rostami A, Ciric B.

J Neurol Sci. 2013 Oct 15;333(1-2):76-87. doi: 10.1016/j.jns.2013.03.002. Epub 2013 Apr 8. Review.

4.

T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease.

O'Connor RA, Cambrook H, Huettner K, Anderton SM.

Eur J Immunol. 2013 Nov;43(11):2818-23. doi: 10.1002/eji.201343689. Epub 2013 Aug 21.

5.

Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.

de Oliveira DM, de Oliveira EM, Ferrari Mde F, Semedo P, Hiyane MI, Cenedeze MA, Pacheco-Silva A, Câmara NO, Peron JP.

Inflammopharmacology. 2015 Dec;23(6):343-54. doi: 10.1007/s10787-015-0252-1. Epub 2015 Nov 11.

PMID:
26559850
6.

Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE.

Rothhammer V, Heink S, Petermann F, Srivastava R, Claussen MC, Hemmer B, Korn T.

J Exp Med. 2011 Nov 21;208(12):2465-76. doi: 10.1084/jem.20110434. Epub 2011 Oct 24.

7.

Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.

Murphy AC, Lalor SJ, Lynch MA, Mills KH.

Brain Behav Immun. 2010 May;24(4):641-51. doi: 10.1016/j.bbi.2010.01.014. Epub 2010 Feb 6.

PMID:
20138983
8.

Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis.

Domingues HS, Mues M, Lassmann H, Wekerle H, Krishnamoorthy G.

PLoS One. 2010 Nov 29;5(11):e15531. doi: 10.1371/journal.pone.0015531.

9.

Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.

Álvarez-Sánchez N, Cruz-Chamorro I, López-González A, Utrilla JC, Fernández-Santos JM, Martínez-López A, Lardone PJ, Guerrero JM, Carrillo-Vico A.

Brain Behav Immun. 2015 Nov;50:101-114. doi: 10.1016/j.bbi.2015.06.021. Epub 2015 Jun 27.

PMID:
26130320
10.

Adiponectin Suppresses T Helper 17 Cell Differentiation and Limits Autoimmune CNS Inflammation via the SIRT1/PPARγ/RORγt Pathway.

Zhang K, Guo Y, Ge Z, Zhang Z, Da Y, Li W, Zhang Z, Xue Z, Li Y, Ren Y, Jia L, Chan KH, Yang F, Yan J, Yao Z, Xu A, Zhang R.

Mol Neurobiol. 2017 Sep;54(7):4908-4920. doi: 10.1007/s12035-016-0036-7. Epub 2016 Aug 11.

PMID:
27514756
12.
13.

Comparison of a classical Th1 bacteria versus a Th17 bacteria as adjuvant in the induction of experimental autoimmune encephalomyelitis.

Smith AJ, Liu Y, Peng H, Beers R, Racke MK, Lovett-Racke AE.

J Neuroimmunol. 2011 Aug 15;237(1-2):33-8. doi: 10.1016/j.jneuroim.2011.05.012. Epub 2011 Jun 28.

14.

Selective ORAI1 Inhibition Ameliorates Autoimmune Central Nervous System Inflammation by Suppressing Effector but Not Regulatory T Cell Function.

Kaufmann U, Shaw PJ, Kozhaya L, Subramanian R, Gaida K, Unutmaz D, McBride HJ, Feske S.

J Immunol. 2016 Jan 15;196(2):573-85. doi: 10.4049/jimmunol.1501406. Epub 2015 Dec 16.

15.

IL-12/IL-23p40 Is Highly Expressed in Secondary Lymphoid Organs and the CNS during All Stages of EAE, but Its Deletion Does Not Affect Disease Perpetuation.

Cravens PD, Hussain RZ, Miller-Little WA, Ben LH, Segal BM, Herndon E, Stüve O.

PLoS One. 2016 Oct 25;11(10):e0165248. doi: 10.1371/journal.pone.0165248. eCollection 2016.

16.

Infection of non-encapsulated species of Trichinella ameliorates experimental autoimmune encephalomyelitis involving suppression of Th17 and Th1 response.

Wu Z, Nagano I, Asano K, Takahashi Y.

Parasitol Res. 2010 Oct;107(5):1173-88. doi: 10.1007/s00436-010-1985-9. Epub 2010 Jul 27.

PMID:
20661746
17.

IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses.

Chong WP, Horai R, Mattapallil MJ, Silver PB, Chen J, Zhou R, Sergeev Y, Villasmil R, Chan CC, Caspi RR.

J Autoimmun. 2014 May;50:12-22. doi: 10.1016/j.jaut.2013.08.003. Epub 2013 Sep 7.

18.

Lineage-Specific Metabolic Properties and Vulnerabilities of T Cells in the Demyelinating Central Nervous System.

Seki SM, Stevenson M, Rosen AM, Arandjelovic S, Gemta L, Bullock TNJ, Gaultier A.

J Immunol. 2017 Jun 15;198(12):4607-4617. doi: 10.4049/jimmunol.1600825. Epub 2017 May 15.

19.

Role of TFH Cells in Promoting T Helper 17-Induced Neuroinflammation.

Quinn JL, Kumar G, Agasing A, Ko RM, Axtell RC.

Front Immunol. 2018 Feb 27;9:382. doi: 10.3389/fimmu.2018.00382. eCollection 2018.

20.

Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.

Kong W, Li H, Tuma RF, Ganea D.

Cell Immunol. 2014 Jan;287(1):1-17. doi: 10.1016/j.cellimm.2013.11.002. Epub 2013 Nov 14.

Supplemental Content

Support Center